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Abstract 
            Diabetes, a common chronic condition, effects many individuals causing poor quality of 
life, expensive medical bills, and devasting medical complications. While health care providers 
try to manage diabetes during short office visits, many patients still struggle to control their 
diabetes at home. Lack of diabetes self-management (DSM) is a potential barrier for people with 
diabetes having to maintain healthy hemoglobin A1cs (HgA1c). In hopes of addressing this 
concern, an evidenced-based intervention; diabetic education and phone calls, using the chronic 
care model as its framework was implemented. The intervention targeted people with type II 
diabetes at a transitional care setting. Measured variables included HgA1c and DSM. Statistically 
significant improvements were seen in reported physical activity. Average improvements were 
seen in HgA1c and DSM after three months of diabetes self-management education (DSME). 
Attrition, cultural sensitivity, and increasing DSME hours should be further evaluated for future 
projects.  
Keywords: diabetes, diabetic patients, chronic care management, care management, 
hemoglobin A1c 
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Diabetes Self-Management Education Effects on Hemoglobin A1c  
Chronic care management (CCM) is a significant part of caring for patients with diabetes 
as it contributes to better patient care and outcomes. Diabetes is a complex disease requiring 
referrals, continuous education, and frequent medication adjustments. All of which are included 
in CCM. With the health risks facing people with diabetes, it is important healthcare providers 
seek alternative methods to care for people with diabetes.  
There are approximately 422 million people living with diabetes worldwide, with a 
predicted increase to 642 million by 2040 (World Health Organization [WHO], 2019; Zou et al., 
2018). About one in every five Americans aged 65 and older have been diagnosed with diabetes 
(Hasche, Ward, & Schluterman, 2017). In Arizona, approximately one-third of people are 
prediabetic and one in 10 are diabetic, representing 2.1 million and 720,000 people, respectively 
(Diabetes Action Plan and Report, 2019). With about 34,000 being newly diagnosed yearly 
(American Diabetes Association [ADA], 2014). Arizona spent an estimated $6.8 billion on 
diabetes care in 2019 (Diabetes Action Plan and Report, 2019).  In 2016, the prevalence of 
diabetes in Yuma County, located in the southwest corner of Arizona, was 12.9% of the 
population aged 20 years and older (Centers for Disease Control and Prevention, n.d.).  The 
county has seen diabetes rates double over the last decade (Yuma Regional Medical Center 
[YRMC], 2016).  
Transitional Care Services serves the Yuma Community providing patients with chronic 
conditions, such as congestive heart failure, chronic obstructive pulmonary disease, and acute 
myocardial infarctions, who need help transitioning home after a hospital discharge (YRMC, 
2019). Their goal is to promote quality of life by enhancing knowledge and management of the 
patient’s chronic conditions (YRMC, 2019). About 90-95% of patients are referred by the only 
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hospital in Yuma County, which had over 12,000 hospital and emergency room diabetes related 
discharges (Contreras & Sandoval-Rosario, 2018). Although Transitional Care Services cares for 
patients with complex chronic conditions, diabetes is not a disease they primarily focus on. 
This information led to the clinically relevant PICO question, in adult patients diagnosed 
with diabetes (P), how does CCM (I) compared to standard care (C) affect HgA1c (O)? 
Literature review of current evidence included 10 critically appraised articles chosen 
from CINHAL, PubMed, and Wiley (see Appendices A and B). Articles selected included five 
randomized controlled trials, two cohort studies, one quasi-experimental, one observational study 
with no control, and a case study. Level of evidence ranged from II-IV. All studies chosen had at 
least one dependent variable (DV) measuring HgA1c. Independent variables showing significant 
improvements in HgA1c were care coordination, telephone calls and education, especially 
related to diabetes self-management (DSM).  
It was determined the proposed evidence-based practice (EBP) project would use 
diabetes self-management education (DSME) and telephone calls to implement CCM to type II 
diabetic patients at Transitional Care Services. The measurable outcomes of the project were 
DSM and HgA1c. The EBP project was informed by the Chronic Care Model (CCMo) because 
evidence has shown it may improve diabetic outcomes, such as HgA1c (National Institute of 
Diabetes and Digestive and Kidney Diseases [NIDDK], n.d.; see Appendix C). By applying the 
elements of the CCMo, which are health systems, decision support, clinical information systems, 
patient self-management support, and community resources, and delivery systems, the project 
hoped to join informed, active patients and a prepared, proactive practice team to improve 
diabetic outcomes (Improving Chronic Illness Care, 2019). Rosswurm and Larabee’s (1999) 
model was chosen as the evidence-based model for this project to serve as guidance throughout 
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the process changes (see Appendix D). The model assists in changes that are healthcare specific 
and strives for improved quality and outcomes.   
Methods 
Participants 
 Adults, 18 years or older, were identified using the electronical health record (EHR) at 
Transitional Care Services with the target goal being 30 participants. Potential subjects of the 
project met the following inclusion criteria: ≥ 18 years old, previously documented type II 
diabetes diagnosis, previously documented HgA1c ≥ 6.5% in last month, English speaking, has 
access to telephone calls for the duration of project, and able to sign consent. Exclusion criteria 
includes: history of dementia, participating in other diabetic studies, and non-English speaking. 
Once identified, a flyer was handed to potential subjects to avoid coercion. If the subject wished 
to participate, consent was obtained. Ethical consideration for the project was processed and 
approved by Arizona State University’s Institutional Review Board and Yuma Regional Medical 
Center’s Innovation Council Advisory Board.  
Study Design 
 All participants had a HgA1c collected from the EHR and completed a diabetes self-
management questionnaire (DSMQ) prior to intervention, which served as pretests. Diabetes 
education was then initiated during the same visit. All participants were given the same 
education by the same individual at individual times. Education included glucose management 
(GM), dietary control (DC), physical activity (PA), and healthcare use (HU). All participants 
were given a take home folder pertaining to the subject matter. Participants were given three 
monthly phone calls to serve as a reminder of the lesson content provided at the educational visit. 
After three months, participants had a new HgA1c collected from the EHR and complete a post-
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DSMQ. Participants who did not have a new HgA1c recorded in EHR after three months or did 
not complete a post-DSMQ were disqualified from the project. Measurable outcomes, HgA1c 
and DSM, were statistically analyzed using a paired sample t-test. 
Hemoglobin A1c 
HgA1c is a blood test reflecting average blood sugars over three months (ADA, 2019). 
The ADA (2019) recommends measuring HgA1c levels at least biannually if patients are 
meeting treatment goals or quarterly if therapy has changed or glycemic goals are not met. 
HgA1c was chosen as a measurable outcome because the ADA (2019) recognizes the blood test 
as a standard of care due to its strong predictability value for diabetic complications. Although is 
it recognized by the Centers for Disease Control and Prevention (2018) and the American 
College of Physicians (2018) as an appropriate diabetic test, there are some limitations. 
Conditions that affect red blood cell turnover might cause discrepancies in HgA1c (ADA, 2019). 
Additionally, HgA1c has shown to have low sensitivity but high specificity. Measuring against a 
single fasting glucose (≥126 mg per dL), the sensitivity and specificity of an HgA1c ≥6.5% for 
detection of diabetes was 47% and 98%, respectively (Selvin, Steffes, Gregg, Brancati, & 
Coresh, 2011). Three years later, repeated fasting glucose (≥126 mg/dL) showed sensitivity 
increased to 67% and specificity remained high at 97% (Selvin, Steffes, Gregg, Brancati, & 
Coresh, 2011). 
Diabetes Self-Management Questionnaire 
DSMQ has 16 questions pertaining to five subscales: GM, DC, PA, HU, and self-care 
summary (SS) (Schmitt et al. 2013). SS is an overall measurement of perceived self-care. During 
its evaluation, the DSMQ was found to be reliable with good factorial validity and a strong 
correlation to HgA1c in patients with type I and II diabetes. It also had good concurrent validity 
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when compared to Summary of Diabetes Self-Care Activities Measure. Overall, internal 
reliability was good with a Cronbach’s α coefficient of 0.84. Its subscales were mostly 
acceptable (GM: 0.77; DC: 0.77; PA: 0.76; HU: 0.60).  
Statistical Analysis 
 Statistical analysis began after data collection was finalized using Intellectus Statistics. A 
two-tailed paired samples t-test was conducted to examine whether the mean difference of DVs 
were significantly different from zero based on an alpha value of 0.05. Based on Shapiro-Wilk 
test and Levene’s test, all DVs’ normality assumptions and homogeneity of variances were met. 
Results 
Demographics 
 In total, 29 participants were recruited. By final data collection, there were nine subjects 
who completed the intervention (see Appendix E). The most frequently observed age range was 
65 years and older (n = 5, 56%). Most subjects were male (n = 8, 89%). Most subjects identified 
as Hispanic/Latino/Spanish (n = 8, 89%). Most subjects had been diagnosed with diabetes 
greater than 10 years ago (n = 5, 56%). The majority of subjects’ highest level of education was 
high school (n = 7, 78%).  
Hemoglobin A1c 
There were mean improvements in pre- and post-HgA1c for final subjects, 8.57% (SD = 
1.92) and 8.29% (SD = 1.77), respectively. The result of the two-tailed paired samples t-test was 
not significant, t(8) = 0.57, p = .587. 
Diabetes Self-Management 
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 Each individual subscale of the DSMQ was statistically analyzed. Each subscale was first 
given a 10-point scale score. The scale score value was used to calculate the two-tailed paired 
samples t-test of each subscale. 
 Glucose Management. There were mean improvements in pre-GM and post-GM, 6.30 
(SD = 3.01) and 7.11 (SD = 2.37), respectively. The result of the two-tailed paired samples t-test 
was not significant, t(8) = -0.70, p = .507. 
 Dietary Control. There were mean improvements in pre-DC and post-DC, 5.07 (SD = 
2.34) and 7.12 (SD = 1.56), respectively. The result of the two-tailed paired samples t-test was 
not significant, t(8) = -0.71, p = .500. 
 Physical Activity. There were mean improvements in pre-PA and post-PA, 6.30 (SD = 
3.98) and 8.40 (SD = 2.02). The result of the two-tailed paired samples t-test was significant, t(8) 
= -2.56, p = .034.  
 Healthcare Use. There were mean decreases in pre-HU and post-HU was 9.39 (SD = 
0.94) and mean of post-HU was 10 (SD = 0). The result of the two-tailed paired samples t-test 
was not significant, t(8) = -1.89, p = .095. 
 Self-Care Summary. The mean of pre-SS was 9.39 (SD = 3.53) and mean of post-SS 
was 10 (SD = 3.11). The result of the two-tailed paired samples t-test was not significant, t(8) = 
0.61, p = .559. 
Project Impact 
 By using the CCMo as the project’s conceptual framework, the project was able to 
combine aspects of the community, such as self-management support, and health systems, 
specifically the EHR, to produce proactive providers. The project encouraged providers to focus 
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on diabetes. A chronic disease which was not a primary focus for providers at the clinic prior to 
the project. 
The framework supported informed, activated patients. Most results were not statistically 
significant. Yet, on average, subjects had lower Hg A1c levels and reported better GM, DC, PA, 
and HU. Furthermore, most subjects had been living with diabetes for 10 or more years and 
reported never receiving DSME prior to the project. Additional notable reports included: 
receiving their first diabetic eye exam after 10 or more years of diabetes diagnosis, increasing 
their daily physical activity, and keeping food and blood glucose logs.  
Project Sustainability 
 Since phone calls were already apart of the clinic’s workflow and care management of 
patients, the project was perceived to have high sustainability moving forward. Nurses at the 
clinic conduct weekly phone calls with patients, which is more frequent than the project required. 
In addition, the initial DSME visit was approximately 20 minutes. Fortunately, the clinic’s 
patient volume and schedule flexibility allowed for this block of time. Seldomly providers were 
delayed seeing their patients. The sustainability of this project would require additional supplies 
for DSME folder packets, employee hourly pay, and time for education. This additional cost 
could be sustained by available reimbursement of DSME from entities, such as the Centers for 
Medicare and Medicaid Services and the CDC. 
Discussion 
 The project did improve HgA1c levels and DSM with the use of DSME as CCM, but 
statistically significant improvements in HgA1c levels were not yielded. Statistically significant 
improvement was seen in reported PA. There was a worsening of reported SS.  
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Findings were congruent to previous literature suggesting significant reduction in HgA1c 
levels are found in those offered greater than 10 hours of DSME services (Beck et al., 2017). 
Over the course of the intervention, the project provided about two hours of DSME per subject.  
Limitations 
The project sample size was small due to large attrition. Subjects were disqualified 
because they did not have a post-HgA1c value in the EHR to collect, they did not answer phone 
calls, or they did not perform a post-DSMQ. Social determinants could have played a factor in 
high rate of attrition. Evidence suggests Latino populations, especially men, struggle with shame 
of illness and lack of interest in health (Testerman & Chase, 2018). 
The project had a short interventional period. Furthermore, the three month period was 
over several holidays. Some subjects expressed they had overly indulged in culturally traditional 
foods over the holiday season.  
Recommendations 
Recommendations to retain subjects include incentivizing the completion of the project. 
Contacting subjects once a month may have lost the interest of subject’s participation without 
incentivization. Having scheduled phone calls could help retain subjects by avoiding missed 
phone calls.  
Increasing DSME hours to greater than 10 could help yield significant results. Increasing 
the hours of DSME could give opportunity to measure greater intervals of time, such as six-, 
nine-, and 12-months. This may give insight to sustainability of the project.  
Most subjects were Hispanic with the highest level of education being high school. 
Subjects could have benefited from culturally centered DSME. In addition, many patients at the 
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clinic only spoke Spanish, which prevented them from being eligible participants. Further studies 
could target Spanish speakers.  
Conclusion 
 CCM is a vital part of any chronic disease. In those with diabetes, CCM is an ongoing 
process that supports individuals with diabetes through the lifelong process of DSM. Tools that 
help individuals meet their HgA1c goals should be promoted to reduce diabetic complications.  
DSME, a component of CCM, has been shown to reduce Hg A1c levels. Additionally, DSME 
has been shown to have a positive impact on diabetes-related costs and complications. While the 
benefits of DSME have been demonstrated in the literature, low utilization of DSME remains.  
Efforts to improve DSME should be explored for improving CCM and lowering Hg A1c.  
This project showed DSME can be used to help improve HgA1c and DSM. Although 
statistical significant were not yielded in HgA1c and most subscales of DSM, average 
improvements were seen in mostly all DV. Attrition rates, cultural sensitivity, DSME hours 
provided, and length of project intervention should be further evaluated to produce significant 
results.   
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Appendix A 
Table 1 
Evaluation Table 
Citation Theory/Con
ceptual 
Framework 
Design/Method/P
urpose 
Sample/Setting Major Variables Measurem
ents/Instru
mentation 
Data Analysis Findings/Results Level or Evidence/Decision for 
Use/Application to Practice 
Holtrop et al. 
(2017). Diabetic 
and obese patient 
clinical outcomes 
improve during a 
care management 
implementation 
in PC.  
 
Funding: 
NIDDK 
 
Bias: No 
conflicts 
recognized 
 
Country: USA 
CCMo Design: Pair-
matched cluster 
randomized trial 
 
Purpose: To 
understand how 
individual 
practices would 
implement care 
management, its 
successes and 
effects on those at 
risk of DM due to 
obesity. 
N – 1,392 
IG – 696 
CG – 696 
 
Demographics: 
M Age – 54.8 
M/F – 50.4%/49.6% 
 
Setting: PC practices that 
are physician-owned 
medical group in 
southeast Michigan 
 
Inclusion: active pt at 
study practices during 
study period, 18 years or 
older, diagnosis of type 2 
DM or obesity 
 
Exclusion: had less than 
12 month life expectancy, 
non-English speaking, 
lived in nursing or group 
home, had substance 
IV1 – care 
management 
which includes 
staffing 
improvements 
and new care 
management 
software and 
modifications to 
EMR 
 
DV1 – A1C 
DV2 – weight  
 
DV3 – BP  
 
DV 4 – LDL  
 
DV5 – BMI 
 
DV6 - AU 
 
As pts 
presented 
for care, 
clinical data 
and 
laboratory 
test were 
collected 
Paired t test, 
McNemar’s 
chi-square 
test, Stuart-
Maxwell 
symmetry 
test, linear 
mixed effects 
model, linear 
regression 
Diabetics: 
DV1 –  
Baseline 
IG – M=8.4, SD = 0.4 
CG – M=7.4, SD=0.4 
12 months 
IG –  
M=7.5, SD=0.1 
CG – 
7.4, SD=0.5 
Unadjusted 
CI - -0.8 (-1.4,-0.3) 
Adjusted 
CI - -0.5 (-1.0, -0.04) 
 
DV2 –  
Baseline 
IG – M=234.1, SD = 8.3 
CG – M=213.7, SD=6.9 
12 months 
IG –  
M=230.4, SD=6.0 
CG – 
M=209.8, SD=9.0 
LOE – Level I 
 
Strengths – RCT design 
 
Weakness – only 10 practices 
participated, which 5 received 
intervention, variability in 
baseline risks factors vs 
comparison pt, especially BMI 
and A1C for diabetics 
 
Conclusions – Findings add to 
the growing EB for the 
effectiveness of CM as an 
effective clinical practice with 
regard to improving DM and 
obesity related outcomes 
 
Feasibility/Applicability – 
findings consistent with 
literature, recommended for 
diabetic pts because of 
significant improvements in 
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Citation Theory/Con
ceptual 
Framework 
Design/Method/P
urpose 
Sample/Setting Major Variables Measurem
ents/Instru
mentation 
Data Analysis Findings/Results Level or Evidence/Decision for 
Use/Application to Practice 
abuse, psychiatric illness, 
or cognitive impairment, 
had DM or impaired 
glucose tolerance due to 
chronic glucocorticoid 
use, polycystic ovary 
syndrome, pituitary 
lesion, or pancreatectomy.  
Unadjusted 
CI – 0.2 (-9.1,9.5) 
Adjusted 
CI - -2.2 (-5.3,0.7) 
 
DV3 –  
Baseline 
IG – M=127.0, SD = 2.0 
CG – M=127.5, SD=0.7 
12 months 
IG –  
M=127.0, SD=2.6 
CG – M=125.8, SD=3.7 
Unadjusted 
CI – 1.8 (-2.1,-5.7) 
Adjusted 
CI – 2.1 (-2.1, -6.2) 
 
DV6 –  
Baseline 
IG – M=26.6, SD = 4.0 
CG – M=24.3, SD=8.7 
12 months 
IG –  
M=21.1, SD=4.5 
CG – 
27.9, SD=11.7 
Unadjusted 
CI - -9.1 (-26.3,8.1) 
Adjusted 
CI - -1.3 (-14.0, -11.4) 
A1C, but will require training 
and therefore, funding. 
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Citation Theory/Con
ceptual 
Framework 
Design/Method/P
urpose 
Sample/Setting Major Variables Measurem
ents/Instru
mentation 
Data Analysis Findings/Results Level or Evidence/Decision for 
Use/Application to Practice 
Solorio et al. 
(2014). Impact of 
chronic care 
coordinator 
intervention on 
diabetes of care 
in a community 
health center 
 
Funding: 
University of 
Washington 
Royal Research 
Fund 
 
Bias: 
observational 
study based on 
retrospective 
study and may 
include bias due 
to confounding 
factors 
 
Country: USA 
CCM Design: 
Retrospective 
cohort study 
design 
 
Purpose: to 
evaluate the 
impact of CCC 
intervention on 
quality of DM 
care within the 
CHC, 
predominantly 
low-income 
Hispanic and non-
Hispanic white pt 
N – 1,483 
IG – 664 
CG – 819 
 
Demographics: 
M Age – 50-59 
M/F – 48.8%/ 51.2% 
 
Setting: Sea Mar CHC 
that provides PC services 
to predominantly low-
income Hispanics and 
non-Hispanic white pt in 
the Washington area 
 
Inclusion:  established dx 
of DM type 2 in EMR in 
the past 12 months, 
current Sea Mar pt with 
clinic visit between 
2/1/2009 and 9/30/2009, 
ages 18-69 years old, have 
at least 2 visits at the same 
clinic in last year, speak 
English or Spanish 
 
Exclusion: older than 69 
years old, DM type 1, 
pregnant, history of organ 
transplant, Cr  2.5 mg/dL, 
dementia, and terminal 
illness 
IV1 – at least 1 
CCC visit, that 
includes case 
management, care 
coordination, and 
self-management 
 
DV1 – process of 
care, including 
A1C tested at 
least twice taken 
3 months apart, 
LDL, AU, retinal 
eye exam, and 
foot exam 
 
DV2 – 
intermediate 
outcomes of DM 
care, including 
A1C < 7.0 %, 
LDL < 100 
mg/dL, BP < 
130/80 mmHg 
 
DV3 – health 
care utilization, 
including number 
of PC visits, at 
least once referral 
to opht, and at 
Data 
collection 
through 
EMR  
Propensity 
score analysis 
to reduce 
effect of 
selection bias, 
linear mixed 
effects model 
during 12 
month pre- 
and 
postenrolleme
nt , R 
statistical 
software, chi-
sqaure test of 
homogeneity, 
two-sample t-
test 
A1C –  
Baseline 
CG – M=8.0, SD= ±1.6 
IG – M=8.4, SD= ±1.6 
p<0.001 
 
DV1 –  
A1C measurements: CI - 
2.63(1.88, 3.68), p < 0.001;  
AU screen: CI- 2.94 (2.07,  
4.17), p < 0.001;  
Retinal exam: CI - 2.27 
(1.59, 3.25), p < 0.001;  
Foot exam: CI - 5.22 (3.42, 
7.98(, p < 0.001 
 
DV2 –  
A1C < 7%:  
CI - 0.70 (0.39, 1.27), p = 
0.242;  
A1C last value: CI - 0.06 
(0.02, 0.13, p = 0.151;  
BP: CI - 0.99 (0.69, 1.42), p 
= 0.968;  
 
DV3 –  
PCP visit: CI -1.39 (1.28, 
1.51), p < 0.001;  
Endo referral: CI - 0.88 
(0.30 - 2.60), p = 0.818;  
Opht referral: CI - 1.59 
(0.86, 2.94), p = 0.142 
LOE – Level IV 
 
Strengths – large sample 
 
Weakness – observational study 
prone to bias, no data on BMI, 
income, marital status, 
employment, education, alcohol 
use and time with DM, missing 
weight and height on some 
participants, data of duration of 
CCC visits is missing 
 
Conclusions – CCC is 
suggested and may benefit pt 
with DM type 2 by improving 
receipt of DM services 
 
Feasibility/Applicability – Due 
to significant findings in 
increases in DM services with 
CCC, diabetic pt may benefit 
from CCC. Therefore, making 
use for CCC.  
 
DSME EFFECTS ON A1C AND DSM   
Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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mentation 
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Use/Application to Practice 
least 1 referral to 
endo  
Swietek et al. 
(2018). Do 
medical homes 
improve quality 
of care for 
persons with 
multiple chronic 
conditions?  
 
Funding: 
Agency for 
Healthcare 
Research and 
Quality 
 
Bias: regression 
model used to 
reduce bias 
 
Country: USA 
 
 
PCMH Design: quasi-
experimental 
 
Purpose: 
examine the 
association 
between PCMH 
enrollment and 
receipt of disease-
specific quality 
measures for 
nonelderly 
Medicaid 
beneficiaries 
 
 
 
 
 
 
 
 
 
 
 
 
 
N – 208,122 
IG – 145,145 
CG – 62,977 
 
Demographics: 
M Age – 43.91 
M/F – 32.4%/ 67.6% 
 
Setting: Com. Care of 
North Carolina, regional 
PC 
 
Inclusion: ages 18-64 
years old; at least 2 
chronic conditions that 
included: DM, asthma, 
hyperlipidemia, 
hypertension, major 
depression and 
schizophrenia; pt with at 
least partial Medicaid 
eligibility; have at least 2 
outpatient or emergency 
department visits or at 
least 1 inpatient visit for 
given condition 
 
Exclusion: Dual 
Medicare and Medicaid 
enrollees 
IV1 – PCMH 
enrollment  
 
DV1 – A1C 
testing 
 
DV2 – attention 
for nephropathy 
 
DV3 – liver 
function tests  
 
DV4 – eye 
examinations 
 
DV5 – Lipid 
profile 
 
DV6 – ACE or 
ARB 
 
DV7 – SABA 
overuse, which is 
4+ canister 
equivalents in 3 
months 
 
DV8 – any 
psychotherapy 
 
Dataset that 
links 
Medicaid 
claims with 
other 
administrati
ve data 
sources 
t-test, chi-
square, linear 
probability 
model, fixed-
effects model 
 
DV1 –  
CG – M=61.5 
IG – M=82.1 
p<0.001 
 
DV2 –  
CG – M=30.3 
IG – M=43.5 
p<0.001 
 
DV3 –  
CG – M=20.7 
IG – M=25.4 
p<0.001 
 
DV4 –  
CG – M=30.0 
IG – M=44.2 
p<0.001 
 
DV5 –  
CG – M=51.0 
IG – M=70.72 
p<0.001 
 
DV6 –  
CG – M=53.3 
IG – M=78.6 
p<0.001 
 
LOE – Level III 
 
Strengths – large sample 
 
Weakness – Not generalized 
population, PCHM was only 
defined as any enrollment in a 
year which may not capture the 
effects of extended duration of 
PCMH 
 
Conclusions – PCMH model 
may improve quality of care for 
pt with MCC 
 
Feasibility/Applicability – 
Significant findings show 
PCMH could have benefits to pt 
with MCC, which shows 
feasibility.  
 
DSME EFFECTS ON A1C AND DSM   
Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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mentation 
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Use/Application to Practice 
DV9 – assertive 
community 
therapy 
DV7 –  
CG – M=7.8 
IG – M=10.4 
p<0.001 
 
Chamany et al. 
(2015). TP 
intervention to 
improve DM 
control: a 
randomized trial 
in New York City 
A1c registry. 
 
Funding: Albert 
Einstein College 
of Medicine 
 
Bias: None 
identified 
 
Country: USA 
CCM Design: RCT 
 
Purpose: 1) to 
evaluate the 
incremental effect 
of patient-
centered TP 
intervention on 
the M A1C levels 
beyond that 
achieved with 
print materials 
mailed to pts and 
providers by the 
DOHMH registry 
intervention; 2) 
determine what 
patient 
demographic and 
psychosocial 
factors mediate 
the effect of the 
interventions; and 
3) provide 
estimates of 
implementation 
costs of the TP 
N – 941 
IG – 443 
CG – 498 
 
Demographics: 
M Age – 56.3, SD 11.7 
M/F – 36.3%/ 63.7% 
 
Setting: South Bronx 
 
Inclusion: pts with DM 
who speak English and/or 
Spanish and reside in the 
South Bronx; > 18 years, 
with DM, who become 
part of the NYC registry 
by virtue of having a 
reported A1C >7% to the 
DOHMH 
 
Exclusion: < 18 years; 
A1C < = 7 %; refuses 
informed consent and 
HIPAA consent; cognitive 
dysfunction as assessed by 
TP; does not read or speak 
IV1 – 
Telephonic: 
between 4-8 
phone calls each 
year for health 
behavior 
counseling to 
improve A1C 
 
CG – standard 
registry: letters 
from the 
DOHMH to 
promote 
improved A1C 
and give lists of 
Bronx resources 
for healthier food 
and activities 
 
DV1 – A1C  
 
DV2 – DM self-
care activities 
DOHMH 
Registry; 
self-report; 
Morisky 
Medication 
Adherence 
four-item 
scale; 
Summary 
of Diabetes 
Self-Care 
Activities 
; PHQ-9; 
Well-Being 
scale of the 
WHO 
 
 
Two-tailed z-
test; Mann–
Whitney U te
st; Sobel test; 
Stata, version 
12.1 MP 
 
DV1 –  
Baseline 
IG – M=9.3, SD = 2.1, 
n=443 
CG – M=9.1, SD=2.0, 
n=498 
12 months 
IG – M=8.4, SD=1.9, 
n=334,  
CG – 
8.6, SD=2.0, n=360 
Statistically significant, p 
<0.05 
LOE – Level II 
 
Strengths – randomized 
 
Weakness – missing primary 
outcome data for 26.3% of 
participants; not generalized and 
focuses on low-incomes, mostly 
Latinos with DM with TP access 
 
Conclusions – TP intervention 
delivered by health educators 
can be an effective tool to 
improve DM control in diverse 
populations, specifically for 
those with worse metabolic 
control identified using a 
registry. 
 
Feasibility/Applicability – The 
intervention is low cost and low-
intensive, making it feasible and 
applicable.   
 
DSME EFFECTS ON A1C AND DSM   
Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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intervention for 
comparison with 
the print 
intervention. 
English or Spanish; no 
DM 
 
Edelman et al. 
(2015). Nurse-led 
behavioral 
management of 
DM and HTN in 
the com. 
practices: a 
randomized trial. 
 
Funding: 
NIDDK 
 
Bias: None 
identified 
 
Country: USA 
CCM Design: RCT 
 
Purpose: To 
assess the 
effectiveness of 
nurse behavioral 
management of 
DM and HTN in 
com. practices 
among pts with 
both diseases. 
N – 377 
IG – 193 
CG – 184 
 
Demographics: 
M Age – 59.6, SD – 10.7  
M/F – 45.1%/ 54.9% 
 
Setting: Practice-based 
research network of com. 
PC practices 
 
Inclusion: adult pts with 
both DM 2 and HTN and 
receiving care at 1 of 9 
com. fee-for-service 
practices; A1C ≥ 7.5% 
but could have well-
controlled HTN and had 
to be taking medications 
for both 
 
Exclusion: DM type 1; 
inability to receive a 
telephone intervention in 
English, participations in 
another diabetes or HTN 
IV1 – 12 calls 
over 2 years: 
from a nurse 
experienced in 
DM and HTN 
management; 
calls were 
tailored to pts’s 
DM- and HTN- 
behavioral 
barriers 
 
CG – 12 calls not 
tailored or 
interactive: calls 
involved health 
issues unrelated 
to DM or HTN 
 
DV1 – A1C: 
measured by 
fingerstick 
 
DV2 – BP: taken 
at each visit, 2 
measures 5 
minutes apart and 
were averaged 
Clinical 
data from 
visits and 
POCT 
Linear mixed 
model; 
covariance 
model; 
Wilcox rank-
sum test; 
generalized 
estimating 
equation 
model 
DV1 –  
Baseline 
IG – M=9.2, SD = 1.5, 
n=193 
CG – M=9.0, SD=1.4, 
n=184 
24 months 
IG – M=8.6,  
CG – 8.5 
CI (-0.3%, 0.5%), p=0.50 – 
not significant 
LOE – Level II 
 
Strengths – blinded, 
randomized 
 
Weakness – intervention was 
ineffective 
 
Conclusions – telephonic nurse 
case management did not lead 
to improvement in A1c or SBP. 
 
 
Feasibility/Applicability – 
Small gains in clinical 
outcomes may add up to an 
important public health impact 
over a large population, the 
study of a modest intervention 
by traditional trial methods may 
not be feasible. 
 
 
DSME EFFECTS ON A1C AND DSM   
Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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Use/Application to Practice 
study, or living in an 
assisted living facility. 
Egede. (2017) 
Telephone-
delivered 
behavioral skills 
intervention for 
African American 
adults with type 2 
DM: an RCT 
 
Funding: 
National Institute 
of 
Health/NIDDK 
 
Bias: None 
identified 
 
Country: USA 
Information-
motivation 
behavioral 
skills model 
 
Design: RCT 
 
Purpose: To 
assess the 
efficacy of a 
combined 
telephone-
delivered 
education and 
behavioral skills 
intervention in 
reducing 
hemoglobin A1C 
levels in African 
Americans with 
type 2 DM 
N – 255 
IG – knowledge: 63, 
skills: 65, combined: 63 
CG – 64 
 
Demographics: 
M Age – 50-64  
M/F – 55.3%/44.7 % 
 
Setting: Medical 
University of South 
Carolina (general internal 
medicine, endo, family 
medicine, and com. PC 
clinics) and the Ralph H. 
Johnson Veterans 
Administration Medical 
Center, both located in 
Charleston, South 
Carolina. 
 
Inclusion: ≥18 years old; 
dx of type 2 DM and A1C 
≥9% at screening visit; 
self-identified as Black or 
African American; taking 
at least 1 oral medication 
for DM, HTN, or 
hyperlipidemia and must 
be willing to use the 
IV1 – DM 
knowledge/infor
mation: 12 DM 
education 
modules over 12 
week period 
based on 
guidelines from 
ADA 
 
IV2 – 
motivation/behavi
oral: pt 
activation, pt 
empowerment, 
and behavioral 
skills training 
delivered via 30 
minute phone call 
ever week for 12 
weeks 
 
IV3 – combined: 
receives weekly 
telephone-
delivered DM 
knowledge/infor
mation, pt 
activation, pt 
empowerment, 
EMR and 
clinical 
visits 
Chi-square; 
ANOVA; 
ANCOVA; 
longitudinal 
model   
DV1 –  
Baseline 
IG –  
Knowledge:  
M=9.3, SD = 1.5, n=63 
Skills:  M=9.2, SD = 2.1, 
n=65 
Combination: M=9.2, SD = 
1.9, n=63 
 
CG – M=9.3, SD=2.1, n=64 
 
12 months (Differences in 
levels of A1C) 
IG –  
Knowledge:  
CI – 0.49(-0.13, 1.11), 
p=0.123 – not significant; 
Skills:  CI – 0.23(-0.38, 
0.83), p=0.456 – not 
significant; 
Combination: CI – 0.48(-
0.10, 1.07), p=0.105 – not 
significant 
 
CG – reference group 
 
LOE – Level II 
 
Strengths – targets vulnerable 
population; no RCT in this 
populations; telephone calls are 
efficacious  
 
Weakness – eligibility between 
screening time and baseline visit 
varied causing drop in eligible 
pts; staff turnover was high 
during study, especially among 
health educators 
 
Conclusions – combined 
education and skills training did 
not achieve greater reductions in 
A1C at 12 months compared to 
CG, educations alone, or skills 
training alone. 
 
Feasibility/Applicability – 
Because telephone calls are low 
cost and nursing staff that are 
not mastered prepared are doing 
education makes this study 
feasible. Modifications must be 
made to show significant 
changes in A1C.  
 
DSME EFFECTS ON A1C AND DSM   
Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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MEMS cap and bottle for 
1 year; speak English; 
access to a telephone for 
the 12 week period 
 
Exclusion: mental 
confusion; participations 
in other DM clinical trials, 
alcohol/drug 
abuse/dependence; active 
psychosis or acute mental 
disorder; life expectancy 
< 6 months. 
and behavioral 
skills 
 
CG – standard 
care with general 
health education 
 
DV1 – A1C at 12 
months 
 
DV2 – cost-
effectiveness and 
change in 
physical activity, 
diet, medication 
adherence, and 
self-monitoring 
of blood glucose 
in 12 months 
Halladay et al. 
(2014) More 
extensive 
implementation 
of the CCM is 
associated with 
better lipid 
control in DM. 
 
Funding: 
Agency of 
Healthcare 
Research and 
CCM Design: 
observational 
study 
 
Purpose:  This 
study examines 
whether higher 
KDIS scores are 
associated with 
improved diabetes 
outcomes. 
 
N – 42 practices 
IG – N/A 
CG – N/A  
 
Setting: 42 PC practices 
in North Carolina 
 
Inclusion: participated 
with a practice coach for 
at least 13 months starting 
in February 2008 or later; 
submitted clinical data 
reports in months 
IV1 – 4 key 
drivers: registries, 
planned care 
template, 
protocols, and 
self-management 
support  
 
CG – standard 
practice: without 
drivers 
 
Clinical 
data and 
KDIS data 
Logistic 
regression; 
odds ratio; 
extra-
binomial 
variation in 
linear model 
DV1 –  
Baseline 
IG – 23 (37%), n=42 
 
12 months 
IG – 4 – not significant 
LOE – Level IV 
 
Strengths – innovative 
approach for QI 
 
Weakness – Short length of data 
(2-3 years), was not significant 
 
Conclusions – Practices that 
implement key changes may 
achieve improved patient 
outcomes in LDL control among 
their pts with diabetes. 
DSME EFFECTS ON A1C AND DSM   
Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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Quality/National 
Institutes of 
Health/National 
Institute of 
Environmental 
Health Sciences  
 
Bias: Lack of 
study design may 
lead to bias. 
 
Country: USA 
10,11,12, and submitted 
another clinical date 
report at some point 
during their second year 
of participation with their 
coach. 
Exclusion: Not noted 
 
DV1 – number of 
practices with pt 
at with A1C < 9% 
 
DV2 – number of 
practices with pt 
with BP <130/80  
 
DV3 – number of 
practices with pt 
with LDL <100 
 
Feasibility/Applicability – 
Needs stronger study design to 
be feasible and applicable. 
 
Carrasquillo et al. 
(2017). Effect of 
a com. health 
worker 
intervention 
among Latinos 
with poorly 
controlled type 2 
DM. 
 
Funding: 
National Heart, 
Blood, and Lung 
Institute, National 
Center for 
Advancing 
Translational 
Sciences and the 
National 
Institutes on 
CCM Design: RCT 
 
Purpose:  To 
compare a CHW 
intervention with 
enhanced 
usual care 
 
N – 300 
IG – 150 
CG – 150 
 
Demographics: 
M Age – 55.2, SD – 7.0 
M/F – 45%/ 55% 
 
Setting: 2 public hospital 
outpatient clinics in 
Miami-Dade County, 
Florida 
 
Inclusion: A1C >8.0% 
 
Exclusion: dx with type 2 
DM < 6 months 
previously, self-reported 
type 1 DM, dx with type 2 
IV1 – A 1-year 
CHW 
intervention 
consisted of home 
visits, telephone 
calls, and group-
level activities. 
 
CG – enhanced 
usual care 
 
DV1 – SBP 
 
DV2 – LDL 
 
DV3 – A1C 
EMR, 
telephone 
calls 
2-tailed t test, 
generalized 
estimating 
equation 
model, chi-
squared test 
DV3 –  
Baseline 
IG – M=9.3, SD = 2.1, 
n=150 
CG – M=9.3 SD=1.9, n=150 
12 months (Adjusted) 
IG – CI - -0.51% (-0.94, -
0.09) - significant 
 
LOE – Level II 
 
Strengths – single-blinded 
RCT, correlates with previous 
evidence 
 
Weakness – does not provide 
evidence on which part of the 
intervention helped lower A1C 
 
Conclusions – Both groups 
showed a statistically significant 
reduction of HbA1c at 6 and 12 
months following baseline.  
 
Feasibility/Applicability – 
Although CHW are not 
expensive compared to the 
average diabetic treatment, 
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Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
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Citation Theory/Con
ceptual 
Framework 
Design/Method/P
urpose 
Sample/Setting Major Variables Measurem
ents/Instru
mentation 
Data Analysis Findings/Results Level or Evidence/Decision for 
Use/Application to Practice 
Minority Health 
and Health 
Disparities 
 
Bias: None noted 
 
Country: USA 
DM younger than 25 
years old, were enrolled in 
intervention studies, 
planned to move from the 
county within the next 
year 
insurance plans may not cover 
their services. 
 
Cykert et al. 
(2016). 
Meaningful use in 
chronic care 
improved DM 
outcomes using 
PC extension 
center model 
 
Funding: 
National 
Coordinator for 
Health 
Information 
Technology, 
North Carolina 
Regional 
Extension Center 
Cooperative 
Agreement, The 
North Carolina 
Health and 
Wellness Trust 
Fund 
 
Primary care 
extension 
center 
model/CCM 
Design: cohort 
study 
 
Purpose: to 
evaluate the 
effectiveness QI 
of EHR on 
diabetes 
 
N – 50 practices 
IG – 50 
CG – N/A 
 
Demographics: 
N/A 
 
Setting:  
 
Inclusion: practices that 
signed up for Regional 
Extension Center for 
Health Information 
Technology services and 
agreed to implement a 
certified EHR system, 
perform QI through onsite 
practice facilitation using 
DM chronic care 
measures, and work 
toward achievement of 
CMS-defined meaningful 
use of their certified EHR. 
 
IV1 – QI: 
provided to 
practices with a 
coach and 
practice team 
engagement at the 
site, or web-based 
communication 
 
DV1 – percentage 
of diabetic pts 
who achieved 
A1C< 7% 
 
DV2 – percentage 
who remained 
with HGB A1C > 
9% for each 
practice site 
EMR, 
onsite 
practice 
facilitation 
Bivariate 
analysis, 
linear 
regression 
model, KDIS 
scores 
DV1 –  
Baseline 
IG – M=41.6, SD = 16.7, 
n=50 
6 months (EHR + practice 
facilitation) 
IG – M = 51.3, SD = 16.0, 
n=45 
6 moths (HER +practice 
facilitation + Meaningful 
Use 
IG – M = 60.0, SD = 11.6, 
n=29 
 
DV2 –  
Baseline 
IG – M=21.6, SD = 11.8, 
n=50 
6 months (EHR + practice 
facilitation) 
IG – M = 20.1, SD = 13.3, 
n=45 
6 moths (EHR +practice 
facilitation + Meaningful 
Use 
LOE – Level IV 
 
Strengths – QI proven to be 
successful in DM management 
 
Weakness – No control 
 
Conclusions – Practice 
facilitation that provided EHR 
and QI coaching support showed 
important improvements in 
diabetes outcomes in practices 
that achieved meaningful use of 
their EHR systems.  
 
Feasibility/Applicability – if 
grant money can be rewarded 
this is feasible. Study is 
applicable since HER are highly 
used in practices. 
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Key: A1C – hemoglobin A1C; ACE – angiotensin-converting enzyme inhibitor; ADA – American Diabetic Association; ARB – angiotensin-receptor blocker; 
AU – microalbumin; BMI – body mass index; BP – blood pressure; CCC – chronic care coordinator; CCMo – chronic care model; CHC – community health 
center; CHW – community health worker; CI – confidence interval; CM – care management; CMS – Centers for Medicare and Medicaid Services; Com. – 
community; Cr – serum creatinine; DM – diabetes; DOHMH – Department of Health and Mental Hygiene; DSME – diabetes self-management education; 
DSMS – diabetes self-management support; DV – dependent variable; Dx – diagnosis; EB – evidence based; EHR – electronic health record; EMR – electronic 
medical record; Endo – endocrinology; HTN – hypertension; IV – independent variable; KDIS – Key Drivers Implementation Scales; LDL – low-density 
lipoprotein; LOE – level of evidence; M – median; MCC – multiple chronic conditions; MEMS – medications event monitoring system; M/F – male/female; N 
– sample; n – subgroup of sample size; N/A – not applicable; NIDDK – National Institute of Diabetes and Digestive and Kidney Diseases; Opht – 
ophthalmology; PCMH – patient centered medical home; PC – primary care; PCP – primary care provider; PHQ-9 – Patient Health Questionnaire; POCT – 
point of care testing; Pt – patient; QI – quality improvement; RCT – randomized controlled trial; SD – standard deviation; TP - telephone 
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Citation Theory/Con
ceptual 
Framework 
Design/Method/P
urpose 
Sample/Setting Major Variables Measurem
ents/Instru
mentation 
Data Analysis Findings/Results Level or Evidence/Decision for 
Use/Application to Practice 
Bias: None noted 
 
Country: USA 
Exclusion: practices that 
had participated in QI 
programs 
IG – M = 15.4, SD = 6.2, 
n=29 
Sepers et al. 
(2015). 
Measuring the 
implementation 
and effects of a 
coordinated care 
model featuring 
DSME within 4 
PCMH. 
 
Funding: 
Bristol-Myers 
Squibb 
Foundation 
 
Bias: None 
identified 
 
Country: USA 
CCMo Design: empirical 
case study, 
retrospective 
 
Purpose:  to 
measure the 
implementation 
and effects of a 
multisite 
coordinated care 
approach that 
delivered DSME 
and DSMS for 
disadvantaged pts 
 
N – 173 
IG – 173  
CG – N/A 
 
Demographics: 
N/A 
 
Setting: 4 PMCHs in 
Jacksonville, Florida, 
Athens County, Ohio, 
Oklahoma City, 
Oklahoma, and Nashville, 
Tennessee 
 
Inclusion: PCMH had to 
be a part of Together on 
DM 
 
Exclusion: Not noted 
IV1 – DSME and 
coordinated care: 
accredited DSME 
program with pt-
tailored curricula, 
DSMS that 
targets unique 
needs of 
underserved 
populations, 
enhanced access 
and linkage to 
care services, and 
practice changes 
aimed at 
improving quality 
of DM clinical 
care 
 
CG – N/A 
 
DV1 – A1C 
 
DV2 – BMI 
 
DV3 – BP 
 
DV4 - LDL 
SPSS 
Statistics 
for 
Windows, 
Paired-
sample t test, 
Pearson 
product-
moment 
correlation 
coefficient 
DV1 –  
Baseline 
IG – M=9.1, SD = 2.4  
6 months 
IG – M=8.5, SD = 2.1  
p = 0.01, significant 
LOE – Level IV 
 
Strengths – pt and staff 
satisfaction implementing 
intervention 
 
Weakness – no control group 
 
Conclusions – DSME and 
DSMS within coordinated care 
settings have the potential to 
improve PCMH practice and 
associated clinical health 
outcomes for populations 
experiencing health disparities. 
 
Feasibility/Applicability – pts 
and staff shared high satisfaction 
with DSME within the PCMH 
setting, making this intervention 
applicable. Testing of the 
intervention at multiple sites can 
be costly. 
 
CHRONIC CARE MANAGEMENT AND A1C 
 
Key: A1C – hemoglobin A1C; CC – controlled case study; CCC – chronic care coordinator; CHW – community health worker; CS – Cohort study; DSME – 
diabetes self-management education; EMR – electronic medical record; LOE – level of evidence; N/A – not applicable; OS – observational study; QE – quasi-
experimental; RCT – randomized controlled trial; TP – telephone; + - significantly improved; ∆ - modifications 
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Appendix B 
Table 2 
Synthesis Table 
Author Holtrop Solorio Swietek Chamany Edelman Egede Halladay Carrasquil
lo 
Cykert Sepers 
Year 2017 2014 2018 2015 2015 2016 2014 2017 2016 2015 
LOE II IV III II II II IV II IV IV 
Design RCT CS QE RCT RCT RCT OS RCT CS CC 
Sample Size 1,392 1,483 208,122 941 377 255 42 300 50 173 
Demographics 
Age (Mean) 54.8 50-59 43.9 56.3 59.6 50-64 N/A 55.2 N/A N/A 
% Male 50.4 48.8 32.4 36.3 45.1 55.3 N/A 45 N/A N/A 
Findings 
Improve A1C X X+ X+ X+ X X  X+  X+ 
Interventions 
CCC X X X    X X  X 
Staff ∆ X        X  
EMR ∆ X          
DSME  X     X   X 
TP Call   X X    X   
Education     X     X 
Registries       X    
Home Visits        X   
Group 
Activities 
       X   
CHW        X   
CHRONIC CARE MANAGEMENT AND A1C 
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Appendix C 
Figure 1 
Chronic Care Model 
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Appendix D 
Figure 2 
Rosswurm and Larabee’s Model 
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Appendix E 
Table 3 
Demographics 
Variable n % 
RACE/ETHINICITY     
    HISPANIC/LATINO/SPANISH 8 88.89 
    WHITE 1 11.11 
    Missing 0 0 
HISTORY OF DIABETES DIAGNOSIS     
    >10 YEARS 5 55.56 
    1-5 YEARS 1 11.11 
    0-1 YEAR 2 22.22 
    5-10 YEARS 1 11.11 
    Missing 0 0 
GENDER     
    MALE 8 88.89 
    FEMALE 1 11.11 
    Missing 0 0 
AGE     
    45-54 4 44.44 
    >65 5 55.56 
    Missing 0 0 
EMPLOYMENT     
    UNEMPLOYED 2 22.22 
    RETIRED 7 77.78 
    Missing 0 0 
EDUCATION     
    HIGH SCHOOL 7 77.78 
    NO FORMAL 2 22.22 
    Missing 0 0 
Note. Due to rounding errors, percentages may not equal 100%. 
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Appendix F 
Budget 
Phase Activities Cost  Subtotal Total 
Preparation Print copies of project 
overview for staff (qty 30) 
$0.60 x 30 $18  
Print copies of consent, 
evaluation, and educational 
material for participants (qty 
30) 
$3 x 30 $90  
Educational session at clinic 
for staff for 30 min:  
site  
snacks  
time of presenter (project 
director) 
 
 
 
$0 
$15 
$15 
$30  
Delivery Site $0 $0  
Educational session (project 
director) 
$15 x 20 
hours 
$300  
Monthly phone calls by 
project director (30 min/call 
x 3 months) 
$15 x 30 
hours  
$450  
Evaluation Front staff scheduling patient 
for visit(10 min/call x 30 
patients) 
$12 x 5 hours $60  
Review and analysis of 
results (10 hours plus 
software) 
$20 x 10 
hours + $60 
$260 $1,208 
  
Budget Justification: Potential revenue and benefits of project exceeds costs. Decreasing A1c 
levels could decrease number of diabetes related visits to hospital and emergency room visits. 
Alongside, meeting quality measures set forth by Yuma Regional Medical Center. 
 
Possible funding: Transitional Care will fund part of the costs, such as site and front staff. Project 
director will volunteer time and provide funding for all other cost.  
